WinstonWınston
Integrative Health Technologies logo

Integrative Health Technologies

IHTI
55
Medical - Diagnostics & Research · Healthcare
Price
$0.00
+0.00 (+0.00%)
Market Cap
$1,626
Winston Score
55
Winston is curious
A decent business — some strong pillars, some weaker.

Share count rising — dilution

+922.4% over 3y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 71K (2003) → 724K (2006)

Integrative Health Technologies, Inc. is a small healthcare company focused on wellness and preventive health services. It offers health assessments, nutritional testing, and related wellness programs aimed at helping individuals understand and improve their overall health. The company operates in the diagnostics and research space, targeting consumers and practitioners interested in integrative or functional medicine approaches.

The company generates revenue primarily through health testing services and wellness program offerings, likely sold directly to consumers or through healthcare practitioners. It is a very small company, with a market cap near zero and thin margins, suggesting limited scale and early-stage operations. The main risk the business faces is its lack of competitive scale — larger diagnostics companies and well-funded wellness platforms have significantly more resources, brand recognition, and distribution, making it difficult for a micro-cap operator like this to grow its customer base and achieve sustainable profitability.

Winston Score History

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+30.0% YoY

Strong revenue growth

EPS Growth

-99.5% YoY

YoY Growth Rate

Earnings declining

R&D Spend

$0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

51.7%ownership

Flat

Insiders holding steady — not selling despite ability to

Cash Runway

~0 months

$10,859 cash & investments

Short runway — potential dilution ahead through share issuance

Strong grower

Integrative Health Technologies is growing revenue at 30% year-over-year. The Winston Score penalises unprofitable companies, but revenue at this pace tells a different story — this is a company still in "build mode."

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
55.8%
Premium pricing power — 55.8% gross margin
Operating Margin
47.4%
Excellent — 47.4% operating margin
ROCE
0.4%
Weak — 0.4% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
+263.8%
Fast-growing sales (263.8% YoY)
EPS YoY
N/A
Data not available
EPS Consistency
4/8 quarters
Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
N/A
Data not available
FCF Margin
271.0%
Converts sales into free cash efficiently (271.0%)

Free cash flow margin above 20%. Out of every $100 in sales, more than $20 is real cash they keep.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
N/A
Data not available
Interest Cover
100.00x
Comfortably covers interest (100.0x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
0.0x
Attractive valuation — P/E 0.0

P/E under 10. The price tag is small relative to last year's profit.

P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial